• Thurs news: Lilly’s weight-loss drug prevents diabetes. Merck pays $588M for bispecific. Amgen speaks out about bone density issues with obesity drug. PTC gets gene therapy approval. JNJ’s 340B legal fight. See more on our front page

Kowa... Whats it really like?

Are you happy with your current job?

  • Yes its great

    Votes: 0 0.0%
  • No I dont like it and am looking for something else

    Votes: 0 0.0%
  • No but the money/benefits are decent

    Votes: 0 0.0%

  • Total voters
    0












They sent out communication. Symphony notified Kowa that they didn’t have data for March from one pharmacy and they had to backtrack and recalculate. All managers were told about this on a conference call.